|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/41 | (2006.01) |
| A61K 31/41 | (2013.01) | ||
| A61K 31/16 | (2006.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61P 25/10 | (2006.01) |
| (11) | Number of the document | 3711758 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18878222.1 |
| Date of filing the European patent application | 2018-11-13 | |
| (97) | Date of publication of the European application | 2020-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2018/013761 |
| Date | 2018-11-13 |
| (87) | Number | WO 2019/098628 |
| Date | 2019-05-23 |
| (30) | Number | Date | Country code |
| 20170151248 | 2017-11-14 | KR |
| (72) |
SHIN, Hye Won , KR
|
| (73) |
SK Biopharmaceuticals Co., Ltd. ,
221, Pangyoyeok-ro
Bundang-gu, Seongnam-si, Gyeonggi-do 13494,
KR
|
| (54) | USE OF CARBAMATE COMPOUND FOR PREVENTING, ALLEVIATING OR TREATING ABSENCE SEIZURE OR EPILEPSY SHOWING ABSENCE SEIZURE |
| USE OF CARBAMATE COMPOUND FOR PREVENTING, ALLEVIATING OR TREATING ABSENCE SEIZURE OR EPILEPSY SHOWING ABSENCE SEIZURE |